Month: March 2025

Over the past 50 years, the management of transfusion-dependent β-thalassemia (TDT) has undergone a remarkable transformation, significantly improving patients’ quality of life and survival. These advancements have been made possible through improvements in transfusion therapy, the development of effective iron chelators, the use of non-invasive tools for monitoring iron overload,…